| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/05/2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 13/05/2024 | 22:19 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:SENS | Senseonics Holdings Inc |
| 13/05/2024 | 22:13 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SENS | Senseonics Holdings Inc |
| 13/05/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 13/05/2024 | 22:04 | Business Wire | Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management | AMEX:SENS | Senseonics Holdings Inc |
| 09/05/2024 | 22:05 | Business Wire | Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution | AMEX:SENS | Senseonics Holdings Inc |
| 02/05/2024 | 14:05 | Business Wire | Senseonics Holdings, Inc. to Participate in Upcoming Conferences | AMEX:SENS | Senseonics Holdings Inc |
| 30/04/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 30/04/2024 | 13:00 | Business Wire | Eversense® CGM System Receives iCGM Designation by the US FDA | AMEX:SENS | Senseonics Holdings Inc |
| 12/03/2024 | 12:00 | PR Newswire (US) | SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS | AMEX:SENS | Senseonics Holdings Inc |
| 08/03/2024 | 14:05 | Business Wire | Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | AMEX:SENS | Senseonics Holdings Inc |
| 06/03/2024 | 14:05 | Business Wire | Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference | AMEX:SENS | Senseonics Holdings Inc |
| 29/02/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 15/02/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 12/02/2024 | 13:00 | PR Newswire (US) | MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM | AMEX:SENS | Senseonics Holdings Inc |
| 12/02/2024 | 13:00 | Business Wire | Medicare Coverage Significantly Expanded for the Eversense E3 CGM System | AMEX:SENS | Senseonics Holdings Inc |
| 06/02/2024 | 14:00 | Business Wire | PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care | AMEX:SENS | Senseonics Holdings Inc |
| 02/01/2024 | 22:05 | Business Wire | Senseonics Holdings, Inc. Announces Business Updates | AMEX:SENS | Senseonics Holdings Inc |
| 09/11/2023 | 22:05 | Business Wire | Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 09/11/2023 | 14:05 | Business Wire | Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference | AMEX:SENS | Senseonics Holdings Inc |
| 30/10/2023 | 21:05 | Business Wire | Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 09/10/2023 | 13:00 | Business Wire | Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes | AMEX:SENS | Senseonics Holdings Inc |
| 26/09/2023 | 14:05 | Business Wire | Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study | AMEX:SENS | Senseonics Holdings Inc |
| 14/09/2023 | 14:05 | Business Wire | Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase | AMEX:SENS | Senseonics Holdings Inc |
| 13/09/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 23:30 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of 1933: [Amend] | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 14:05 | Business Wire | Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital | AMEX:SENS | Senseonics Holdings Inc |
| 07/09/2023 | 22:19 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | AMEX:SENS | Senseonics Holdings Inc |
| 10/08/2023 | 22:34 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | AMEX:SENS | Senseonics Holdings Inc |
| 10/08/2023 | 22:15 | Business Wire | Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results | AMEX:SENS | Senseonics Holdings Inc |